LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

Search

Neogen Corp

Slēgts

SektorsVeselības aprūpe

5.4 -2.35

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

5.39

Max

5.84

Galvenie mērījumi

By Trading Economics

Ienākumi

649M

36M

Pārdošana

-16M

209M

P/E

Sektora vidējais

657.5

106.172

EPS

0.05

Peļņas marža

17.371

Darbinieki

2,974

EBITDA

667M

89M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+46.68% upside

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

172M

1.4B

Iepriekšējā atvēršanas cena

7.75

Iepriekšējā slēgšanas cena

5.4

Ziņu noskaņojums

By Acuity

76%

24%

60 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Neogen Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 20. nov. 23:07 UTC

Tirgus saruna

Evidence Of Broad Australian Economic Upswing Mounts -- Market Talk

2025. g. 20. nov. 22:22 UTC

Tirgus saruna

Auckland Airport Has Edge Over Transurban In Infrastructure Stocks -- Market Talk

2025. g. 20. nov. 22:08 UTC

Tirgus saruna

Revenues of Texas Battery Projects Drop Sharply -- Market Talk

2025. g. 20. nov. 21:57 UTC

Peļņas

Walmart Reports Strong Sales Growth, Raises Outlook -- 5th Update

2025. g. 20. nov. 21:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2025. g. 20. nov. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 20. nov. 21:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Health Care Roundup: Market Talk

2025. g. 20. nov. 21:50 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2025. g. 20. nov. 21:31 UTC

Peļņas

Nvidia's Strong Results Show AI Fears Are Premature -- Update

2025. g. 20. nov. 21:23 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

2025. g. 20. nov. 21:07 UTC

Peļņas

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

2025. g. 20. nov. 21:06 UTC

Peļņas

Webull 3Q Rev $156.9M >BULL

2025. g. 20. nov. 21:06 UTC

Peļņas

Webull 3Q EPS 7c >BULL

2025. g. 20. nov. 21:05 UTC

Peļņas

Intuit 1Q Sales Jump, CFO Cites AI Demand From Mid-Sized Businesses -- Interview

2025. g. 20. nov. 21:04 UTC

Peļņas

Mid-Sized Businesses Want to Automate Tasks With AI, Intuit CFO Says >INTU

2025. g. 20. nov. 21:04 UTC

Peļņas

Intuit's AI Offerings Attracted More Mid-Sized Businesses in 1Q, CFO Says >INTU

2025. g. 20. nov. 21:04 UTC

Peļņas

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Sees 2Q Rev $4.52B-$4.55B >INTU

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Sees FY26 GAAP Operating Income $5.78B to $5.86B

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Sees 2Q Adj EPS $3.63-Adj EPS $3.68 >INTU

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Expects FY26 Global Business Solutions Rev Growth of 15.5% to 16.5%, Excluding Mailchimp

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Expects FY26 Consumer Rev Growth of 8% to 9%

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Expects FY26 Global Business Solutions Rev Growth of 14% to 15%

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Backs FY26 Rev $21B-$21.19B >INTU

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Backs FY26 Adj EPS $22.98-Adj EPS $23.18 >INTU

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit 1Q Consumer Rev $894M

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Sees 2Q EPS $1.76-EPS $1.81 >INTU

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Backs FY26 Guidance

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit Backs FY26 EPS $15.49-EPS $15.69 >INTU

2025. g. 20. nov. 21:00 UTC

Peļņas

Intuit 1Q Global Business Solutions Rev $3B

Salīdzinājums

Cenas izmaiņa

Neogen Corp Prognoze

Cenas mērķis

By TipRanks

46.68% augšup

Prognoze 12 mēnešiem

Vidējais 8.17 USD  46.68%

Augstākais 10 USD

Zemākais 6.5 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Neogen Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

4 ratings

1

Pirkt

3

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

5.17 / 5.99Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Weak Bearish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

60 / 374 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
help-icon Live chat